Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Tags:

Encore Takes Chattanooga Express, Repeats Orthopedic Purchasing Move

This article was originally published in The Gray Sheet

  • News

Executive Summary

Encore Medical's annual sales are expected to surpass $100 mil. following the purchase of privately held orthopedic rehabilitation equipment maker Chattanooga Group

You may also be interested in...



Ceramic-On-Ceramic Hip, First In-House Spine Implant Developed By Encore

Encore Medical says it expects to supply the third ceramic-on-ceramic hip implant to the U.S. market, behind Stryker and Wright Medical

Ceramic-On-Ceramic Hip, First In-House Spine Implant Developed By Encore

Encore Medical says it expects to supply the third ceramic-on-ceramic hip implant to the U.S. market, behind Stryker and Wright Medical

AbilityOne To Double Rehabilitation Sales To $200 Mil. With S&N Rehab Unit

Smith & Nephew will retain a 21.5% equity interest in AbilityOne, which acquired S&N's rehabilitation business for $123 mil. in a deal announced March 27

Table

View full table

Related Content

Medtech Insight
Tags:
Latest Headlines

‘Core Pillars’ Of Safety And Innovation Take Center Stage In FDA Reports

Behavioral Health Company Two Chairs Secures $72M In Equity And Debt Infusion

Clinical Trial Diversity Requires Sponsors Work With An Assortment Of Patient Advocates, Community Organizations

Israeli Company Lands De Novo Clearance For Digital Bone Marrow Application

See All
UsernamePublicRestriction

Register

MT015809

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By